- GlobeNewswire•9 days ago
LAWRENCEVILLE, N.J., March 16, 2017-- Celsion Corporation, an oncology drug development company, today announced financial results for the year ended December 31, 2016 and provided an update on its development ...
- Zacks•10 days ago
At this juncture, we advise investors to forget Gilead (GILD), a Zacks Rank #4 (Sell) stock, and invest in some other small cap biotech stocks (market capitalization below $200 million) that carry an impressive Zacks Rank.
- GlobeNewswire•16 days ago
Celsion Corporation to Hold Year-End 2016 Financial Results Conference Call on Thursday, March 16, 2017
LAWRENCEVILLE, N.J., March 09, 2017-- Celsion Corporation announced today that the Company will host a conference call to discuss year-end 2016 financial results and provide an update on its development ...
CLSN : Summary for Celsion Corporation - Yahoo Finance
Celsion Corporation (CLSN)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||0.21 x 1200|
|Ask||0.28 x 2500|
|Day's Range||0.26 - 0.28|
|52 Week Range||0.19 - 1.78|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.32|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|